A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1994
12/20/1994	US5374731 Amino acid derivatives with renin-inhibiting properties, a process for the preparation thereof, agents containing these, and the use thereof
12/20/1994	US5374730 Oxidation of substituted pyridine-benzimidazole sulfides to form amide sulfinyl compounds, then alkaline hydrolysis to form sulfinyl carboxylates and decarboxylation
12/20/1994	US5374722 Bridged benzazepines
12/20/1994	US5374721 Benzo-fused lactams promote release of growth hormone
12/20/1994	US5374719 Process for converting loracarbef dihydrate to loracarbef monohydrate
12/20/1994	US5374711 Chemical modification of 2"-amino group in elsamicin a
12/20/1994	US5374710 Compounds which release nitric oxide upon illumination
12/20/1994	US5374661 Composition and method for transdermal delivery of diclofenac
12/20/1994	US5374660 Asministering a benzoic hydrazide to treat antigrowth of fibroblasts, fibronectins, collagen
12/20/1994	US5374659 Xanthan gum, pregelatinized starch, polyoxyethylene sorbitan monooleate, taste masking composition, flavoring agent, water and drug
12/20/1994	US5374658 Selective suppression of destructive cells by treating cells or tissues with spermine dialdehyde before transplanting
12/20/1994	US5374657 Microbial oil mixtures and uses thereof
12/20/1994	US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them
12/20/1994	US5374655 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
12/20/1994	US5374652 Substituted naphthylmethylene- or tetrahydronaphthylmethylene-derivatives of 2-oxoindole
12/20/1994	US5374651 Hypertensive agents; inhibit nitric oxide production
12/20/1994	US5374649 Indole derivatives and pharmaceutical use thereof
12/20/1994	US5374648 Nervous system disorders
12/20/1994	US5374647 Antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides
12/20/1994	US5374643 Antiischemic agents
12/20/1994	US5374640 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
12/20/1994	US5374638 Six membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthma
12/20/1994	US5374637 N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
12/20/1994	US5374636 2,3-trans-disubstituted tropane compounds which have useful pharmaceutical utility
12/20/1994	US5374635 Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis
12/20/1994	US5374634 Treating osteoporosis
12/20/1994	US5374633 Mixtures of nitrogen-heterocyclic antifungal compounds, fatty acid esters, propylene glycol and drugs, for increasing dosage by promoting absorption
12/20/1994	US5374632 2,3-dihydro-1-(8-methyl-1,2,4-triazolo[4,3-B]-pyridazin-6-yl)-4(1H)-pyridinone
12/20/1994	US5374629 Vitamin D analogues
12/20/1994	US5374628 Aryl and heteroaryl(phosphinylmethyl)phosphonate squalene synthetase inhibitors and method
12/20/1994	US5374616 Compositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factor
12/20/1994	US5374560 Method for screening and distinguishing between cobalamin and folic acid deficiency based on assay for cystathionine and 2-methylcitric acid
12/20/1994	US5374552 Pure culture of Actinomadura species, mutants
12/20/1994	US5374537 Protection of moist stratified squamous epithelia against damage from noxious luminal agents
12/20/1994	US5374532 Method for determining susceptibility to escherichia coli urinary tract infections and method for diagnosing secretors and nonsecretors
12/20/1994	US5374432 Topical anti-infective ointment containing silver or silver salts and antibiotics
12/20/1994	US5374422 Adsorption; water swellable
12/20/1994	EP0650366A4 Compositions and methods for treating wounds.
12/20/1994	CA1333616C 19-nor-vitamin d compounds
12/20/1994	CA1333606C Substituted 2-phenyl-4-quinoline carboxylic acids
12/20/1994	CA1333603C Sulfamoyl-2-benzofurancarboxylic acid derivative
12/20/1994	CA1333602C Metalloporphyrin derivatives, their preparation, their application as medecines and their use for the preparation of hybrid molecules
12/20/1994	CA1333601C Macrolide compounds
12/20/1994	CA1333600C Process for the preparation of macrolide compounds
12/20/1994	CA1333599C Macrolide compounds
12/20/1994	CA1333597C 16,17-acetalsubstituted androstane-17.beta.-carboxylic acid esters
12/20/1994	CA1333571C Preventing agent for human immunodeficiency virus infection comprising menfegol
12/20/1994	CA1333570C Topically applicable preparations for treatment of presbyderma
12/20/1994	CA1333569C Method of treatment for autoimmune diseases
12/20/1994	CA1333568C Lipid emulsion
12/20/1994	CA1333567C Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
12/20/1994	CA1333565C Process for the preparation of highly stable, soft gelatine capsules for therapeutical purposes
12/19/1994	CA2125822A1 Therapeutic agent for alzheimer's disease
12/18/1994	CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them
12/18/1994	CA2125121A1 Antibiotic Combination
12/17/1994	CA2125936A1 Pharmaceutical composition
12/17/1994	CA2125802A1 Alicyclic phospholipase a2 inhibitors
12/16/1994	CA2125762A1 Loracarbef hydrochloride c1-c3 alcohol solvates and uses thereof
12/16/1994	CA2125620A1 Ipsapirone medicament formulation
12/16/1994	CA2102003A1 1-.beta.-methyl-2-thiolic carbapenem derivatives
12/15/1994	DE4418796A1 Compositions which can be used orally and counteract plaque and gingivitis
12/15/1994	DE4319556C1 Use of 1,8-cineole for the treatment of bronchopulmonary disorders
12/15/1994	DE4319554A1 Use of essential oils for suppressing the release of arachidonic acid
12/15/1994	CA2125804A1 13,14-dihydro-pgf2.beta. and its isopropyl ester
12/15/1994	CA2125725A1 Urea derivative containing heterocyclic ring
12/15/1994	CA2124912A1 Therapeutic composition
12/14/1994	EP0628630A2 Trehalose-releasing enzyme, and its preparation and uses
12/14/1994	EP0628569A1 Triterpene derivatives and endothelin-receptor antagonists containing the same
12/14/1994	EP0628562A1 Cephalospornis having in position 7 as substituted axymino radical, intermediates, processes for their preparation and their use as medicaments
12/14/1994	EP0628561A1 Process for preparing cephalosporin compounds from reactive organic acid derivatives
12/14/1994	EP0628557A1 Biphenylmethane derivatives, the use of them and pharmacological compositions containing same
12/14/1994	EP0628556A1 Imidazopyridines
12/14/1994	EP0628555A1 Substituted (2-oxo-1-benzimidazolinyl)-piperidines, process for their preparation and their use as antiretroviral agents
12/14/1994	EP0628551A1 Semicyclic urea derivatives as antihistaminic agents
12/14/1994	EP0628550A2 Pyridazines as interleukin-1beta converting enzyme inhibitors
12/14/1994	EP0628548A1 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine
12/14/1994	EP0628545A1 13,14-Dihydro-PGF2BETA and its isopropyl ester
12/14/1994	EP0628543A1 Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them
12/14/1994	EP0628538A1 Process for the acylation of threonine derivatives and their use in the preparation of 1,4-dihydropyridines
12/14/1994	EP0628313A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with dinretics or calcium antagonists
12/14/1994	EP0628312A1 Anti-contraceptive composition
12/14/1994	EP0628311A1 Antidepressant
12/14/1994	EP0628310A1 Use of partially known substituted chromanes as medicine, new products and process for their preparation
12/14/1994	EP0628309A1 Use of O-esters of L-carnitine for the treatment of dermatoses
12/14/1994	EP0628308A1 Use of O-esters of L-carnitine with aromatic acids for the treatment of dermatoses
12/14/1994	EP0628307A2 Methods for administering biological agents and microparticle compositions useful in these and other methods
12/14/1994	EP0628302A2 Oral composition containing salicylanilide antibacterial agent
12/14/1994	EP0628288A2 Medical probe
12/14/1994	EP0628052A1 Alkali metal 8,9-dehydroestrone sulfate esters
12/14/1994	EP0628049A1 Substituted benzimidazoles, process for their preparation as well as their use
12/14/1994	EP0628047A1 Novel therapeutical use of pyridylpyrrolothiazole carboxamide derivatives
12/14/1994	EP0628046A1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists
12/14/1994	EP0628045A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists
12/14/1994	EP0628044A1 Therapeutic nucleosides
12/14/1994	EP0628043A1 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
12/14/1994	EP0628042A1 Serotoninergic ergoline derivatives
12/14/1994	EP0628041A1 Heterocyclic compounds and their preparation and use
12/14/1994	EP0628040A1 Indole derivatives as steroid 5 alpha-reductase inhibitors
12/14/1994	EP0628038A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
12/14/1994	EP0628036A1 N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea compounds having lipoxygenase inhibitory activity

1 ... 7058 7059 7060 7061 7062 7063 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 7077 7078 ... 7860